Robert F. Kennedy Jr., Health Secretary of the United States, has clarified that he did not have any personal conversation with President Trump regarding the nomination of Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC). Kennedy informed lawmakers on Tuesday that he had met with Schwartz on several occasions before her nomination, to discuss her qualifications and views on various health issues. During a hearing of the House Energy and Commerce subcommittee, Kennedy addressed the speculations and rumors surrounding the appointment of Erica Schwartz. He stated that he did not play any role in recommending her for the position, nor did he have any direct communication with the President about her nomination. Kennedy further explained that his meetings with Schwartz were focused on her expertise and experience in the field of public health. As the Health Secretary, he is responsible for ensuring that the CDC is led by a capable and competent individual, and he believed that Schwartz was the right candidate for the job. Schwartz, a physician and public health advocate, has an impressive track record, having previously served as the Chief Medical Officer of the New York City Department of Health and Mental Hygiene. She is also the founder and director of the Montefiore-Einstein Center for Bioethics and has been widely recognized for her contributions in the field of healthcare. Kennedy emphasized that his decision to support Schwartz's nomination was based on her qualifications and not on any political considerations. He also revealed that he had received positive feedback from various stakeholders in the healthcare industry about Schwartz's capabilities and suitability for the role. The nomination of Erica Schwartz has been widely applauded by the medical community and public health experts. Many see her as a highly qualified and visionary leader who will bring a fresh perspective to the CDC and help address the pressing health challenges facing the nation. During her confirmation hearing, Schwartz highlighted her commitment to promoting evidence-based policies and addressing health equity and disparities. She also expressed her willingness to work closely with other agencies and stakeholders to ensure that the CDC fulfills its vital role in protecting and promoting the health and well-being of all Americans. As the COVID-19 pandemic continues to ravage the country, the role of the CDC in managing the crisis has become more crucial than ever. It is essential that the agency is led by a competent and experienced individual like Erica Schwartz, who can guide the nation through these challenging times. Kennedy's statement has put an end to all the speculations and doubts surrounding Schwartz's nomination. It is reassuring to know that the decision to appoint her was based on her qualifications and expertise, and not influenced by any political motives. The House Energy and Commerce subcommittee has also expressed confidence in Schwartz's abilities and has approved her nomination, paving the way for her to lead the CDC. With her vast experience and unwavering commitment to public health, Erica Schwartz is undoubtedly the right person to lead the agency at this critical juncture. In conclusion, the nomination of Erica Schwartz as the new director of the CDC is a testament to the government's commitment to strengthening the nation's public health system. With her knowledge, expertise, and leadership, she is poised to make a significant impact in the fight against the pandemic and other health challenges facing the country. Let us welcome her with open arms and support her in her endeavors to safeguard the health and well-being of all Americans.